BERLIN (Reuters) – Swiss pharmaceutical group Novartis is winding up the German biotech company Morphosys, which it acquired at the beginning of the year, German news outlet WirtschaftsWoche reported on Thursday, saying 330 jobs would be affected.
“In November 2024, we made the decision to close the Morphosys sites in Germany and the U.S. by the end of 2025 and to integrate all portfolio activities into Novartis,” WiWo cited Novartis as saying.
Novartis did not immediately respond to an emailed request for comment from Reuters.
($1 = 0.9610 euros)
(Writing by Friederike Heine; Editing by Madeline Chambers)
When it comes to modern politics, it's not just about policies – it's about how you sell them. And according to billionaire entrepreneur Mark Cuban, Democrats
I started working remotely in 2017 to combine international travel with my career.My parents thought that decision was reck
CBS News spoke with more than a dozen people with knowledge of events at Mar-a-Lago in the weeks between Election Day and Inauguration Day. They requested anony
Per the Wall Street Journal, the percent of Harvard MBAs graduating without a job 3 months later has hit a record level. 23% are